Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Jan van de Winkel

genmab.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Nvidia to return 50% of free cash flow via dividends and share buybacks

Macy's Rises 5%: The Department Store Fighting Back in Amazon's World

Credo Technology Expands AI Footprint With New Product Launches

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Camping World Holdings, Inc. to Secure Counsel Before Important Deadline in Securities Class Action – CWH

NVIDIA's Huge China Win, But Tariff Could Ruin It

Saab: Revitalized War Environment Extends Growth And Supports Upgrade

Allegion plc (ALLE) Presents at JPMorgan Industrials Conference 2026 Transcript

Green Dot: I'm Finally Seeing The Bull Case Play Out (Rating Upgrade)

AMD stock rises over 1% even as markets fall: here's why

Hot U.S. inflation report sinks gold, silver

Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) Soars 5.2%: Is Further Upside Left in the Stock?

CRWV Stock Falls 15% in a Month: Should You Stay Invested or Exit Now?

Kraft Heinz Inks Breakthrough Deal With National Football League as First-Ever Condiment Partner

Here's what Disney's new CEO Josh D'Amaro told employees on his first day

JAAA: Strong AAA-Rated CLO ETF, Outstanding Risk-Return, Good Income

Workato Named a Leader in the 2026 Gartner® Magic Quadrant™ for iPaaS for the 8th Consecutive Time

Amazon or Meta: Which Recent Bill Ackman Buy Has More Upside?

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Snowflake Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNOW

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST

Lululemon Says It Wants To Sell More Clothes at Full Price. Its Stock Is Climbing.

About